Provigil Buyers Lose Cert. In Pay-For-Delay Suit

A Pennsylvania federal judge denied certification Monday for purchasers who say Ranbaxy Laboratories Ltd. inked pay-for-delay deals with Provigil maker Cephalon, ruing that a proposed class of about two dozen does...

Already a subscriber? Click here to view full article